ADENOSINE
- Product NDC
- 51662-1345
- 11-digit product format
- 516621345
- Labeler code
- 51662
- Product ID
- 51662-1345_ef6d5098-ac66-42c7-e053-2995a90aa48f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ADENOSINE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA203883
- Marketing category
- ANDA
- Marketing start
- 2018-11-30
- Marketing end
- 0000-00-00
- Substance
- ADENOSINE
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51662-1345-1 | ADENOSINE | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | | 4 |
| 51662-1345-1 | ADENOSINE | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51662-1345 | ADENOSINE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 4 | Legacy NDC, 2 package rows | 20221211_7be465d5-f2d6-99db-e053-2991aa0a52f0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51662-1345-1 | 51662134501 | 1 VIAL, SINGLE-DOSE in 1 CARTON (51662-1345-1) > 20 mL in 1 VIAL, SINGLE-DOSE | 2018-11-30 | 0000-00-00 | No | No | Current |